MEDIA RELEASE NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN New USD 2.0 billion multi-currency revolving credit ...

Richard Saynor wants to transform Sandoz Group AG into a world champion in copying leading-edge drugs, including anti-obesity and biological treatments, with the goal of bringing them to the masses.

The settlement will be paid by the end of the year, subject to court approval, and won’t affect Sandoz’s guidance for 2024 and the medium term, the company said. The Basel-based group said the ...

Its leading portfolio of more than 1,500 products addresses diseases from common colds to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to the year 1886. Its history of ...

The roots of Sandoz date back to 1886, when chemical company Kern & Sandoz was established in Basel by Dr Alfred Kern and Edouard Sandoz. By 1895, the company had produced its first pharmaceutical ...

Basel, Switzerland-headquartered Sandoz has signed an agreement to acquire US rights to Cimerli, a biosimilar of Roche and Novartis’ ophthalmology therapy Lucentis (ranibizumab), from Coherus ...

concurrently appointed President Region International and a member of the Sandoz Executive Committee Basel, February 3, 2025 – Sandoz, the global leader in generic and biosimilar medicines ...

Born on March 21, 1881 in Basel, Switzerland, he was encouraged to pursue his artistic talents by his parents. In 1908, he moved to Paris to study art and remained there for much of his life. Sandoz’s ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Basel, February 24, 2025 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, announces the ...

Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the ...

Proceeds used to fully repay USD 750 million equivalent in USD and EUR term loans and extend debt maturities to 2035, while reducing overall interest expenses Basel, March 31, 2025 – Sandoz (SIX ...